Genome-Scale CRISPR-Cas9 Knockout Screening in Human Cells

Cited by (1,042)

Items 701–800 of 1,042

1. CARM1-expressing ovarian cancer depends on the histone methyltransferase EZH2 activity
   Sergey V. Karakashev, Hengrui Zhu, Shuai Wu, Yuhki Yokoyama, Benjamin Guy Bitler, Pyoung Hwa Park, Jeong‐Heon Lee, Andrew V. Kossenkov, Krutika Satish Gaonkar, Huihuang Yan et al. · 2018 · Nature Communications
2. FHL1 is a major host factor for chikungunya virus infection
   Laurent Meertens, Mohamed Lamine Hafirassou, Thérèse Couderc, Lucie Bonnet‐Madin, Vasiliya Kril, Beate Mareike Kümmerer, Athéna Labeau, Alexis Brugier, Etienne Simon‐Lorière, Julien Burlaud‐Gaillard et al. · 2019 · Nature
3. Electron transport chain activity is a predictor and target for venetoclax sensitivity in multiple myeloma
   Richa Bajpai, Aditi Sharma, Abhinav Achreja, Claudia L. Edgar, Changyong Wei, Arusha Siddiqa, Vikas Anand Gupta, Shannon M. Matulis, Samuel K. McBrayer, Anjali Mittal et al. · 2020 · Nature Communications
4. Silencing of LINE-1 retrotransposons is a selective dependency of myeloid leukemia
   Zhimin Gu, Yuxuan Liu, Yuannyu Zhang, Hui Cao, Junhua Lyu, Xun Wang, Annika Wylie, Simon J. Newkirk, Amanda E. Jones, Michael Lee et al. · 2021 · Nature Genetics
5. C5aR1-positive neutrophils promote breast cancer glycolysis through WTAP-dependent m6A methylation of ENO1
   Baochi Ou, Yuan Liu, Xiaowei Yang, Xiaojun Xu, Yunwen Yan, Jingjie Zhang · 2021 · Cell Death and Disease
6. miR-6077 promotes cisplatin/pemetrexed resistance in lung adenocarcinoma via CDKN1A/cell cycle arrest and KEAP1/ferroptosis pathways
   Guoshu Bi, Jiaqi Liang, Mengnan Zhao, Huan Zhang, Xing Yu Jin, Tao Lu, Yuansheng Zheng, Yunyi Bian, Zhencong Chen, Yiwei Huang et al. · 2022 · Molecular Therapy — Nucleic Acids
7. CRISPR engineering in organoids for gene repair and disease modelling
   Geurts, Maarten H., Clevers, Hans · 2023 · Nature Reviews Bioengineering
8. TRIM28 promotes the escape of gastric cancer cells from immune surveillance by increasing PD-L1 abundance
   Xiaoxiao Ma, Shuqin Jia, Gangjian Wang, Min Liang, Ting Guo, Hong Du, Sisi Li, Xiaomei Li, Longtao Huangfu, Jianping Guo et al. · 2023 · Signal Transduction and Targeted Therapy
9. Differentiation-Dependent KLF4 Expression Promotes Lytic Epstein-Barr Virus Infection in Epithelial Cells
   Dhananjay M. Nawandar, Anqi Wang, Kathleen R. Makielski, Denis Lee, Shidong Ma, Elizabeth A. Barlow, Jessica A. Reusch, Ru Jiang, Coral K. Wille, Deborah Greenspan et al. · 2015 · PLoS Pathogens
10. A humanized MDCK cell line for the efficient isolation and propagation of human influenza viruses
    Kosuke Takada, Chiharu Kawakami, Shufang Fan, Shiho Chiba, Gongxun Zhong, Chunyang Gu, Kohei Shimizu, Sarah Takasaki, Yuko Sakai‐Tagawa, Tiago J. S. Lopes et al. · 2019 · Nature Microbiology
11. Genome-scale in vivo CRISPR screen identifies RNLS as a target for beta cell protection in type 1 diabetes
    Erica P. Cai, Yuki Ishikawa, Wei Zhang, Nayara C. Leite, Jian Li, Shurong Hou, Badr Kiaf, Jennifer Hollister‐Lock, Neşe Kurt Yılmaz, Celia A. Schiffer et al. · 2020 · Nature Metabolism
12. CRISPR screens in plants: approaches, guidelines, and future prospects
    Christophe Gaillochet, Ward Develtere, Thomas B. Jacobs · 2021 · The Plant Cell
13. Deficiency in coatomer complex I causes aberrant activation of STING signalling
    Annemarie Steiner, Katja Hrovat-Schaale, Ignazia Prigione, Chien‐Hsiung Yu, Pawat Laohamonthonkul, Cassandra R. Harapas, Ronnie Ren Jie Low, Dominic De Nardo, Laura F. Dagley, Michael J. Mlodzianoski et al. · 2022 · Nature Communications
14. Genome-wide CRISPR screen for PARKIN regulators reveals transcriptional repression as a determinant of mitophagy
    Potting, Christoph, Crochemore, Christophe, Moretti, Francesca, Nigsch, Florian, Schmidt, Isabel, Manneville, Carole, Carbone, Walter, Knehr, Judith, DeJesus, Rowena, Lindeman, Alicia et al. · 2018 · Proceedings of the National Academy of Sciences
15. CRISPR/Cas9-Mediated Gene Knock-Down in Post-Mitotic Neurons
    C. Straub, Adam J. Granger, Jessica L. Saulnier, Bernardo Luis Sabatini · 2014 · PLoS ONE
16. Versatile in vivo regulation of tumor phenotypes by dCas9-mediated transcriptional perturbation
    Christian Joerg Braun, Peter M. Bruno, Max A. Horlbeck, Luke A. Gilbert, Jonathan S. Weissman, Michael T. Hemann · 2016 · Proceedings of the National Academy of Sciences
17. Drug mechanism‐of‐action discovery through the integration of pharmacological and CRISPR screens
    Emanuel Gonçalves, Aldo Segura‐Cabrera, Clare Pacini, Gabriele Picco, Fiona M. Behan, Patricia Jaaks, Elizabeth A. Coker, Donny van der Meer, Andrew S. Barthorpe, Howard W. Lightfoot et al. · 2020 · Molecular Systems Biology
18. Photoaffinity labelling strategies for mapping the small molecule–protein interactome
    Nikolas R. Burton, Phillip Kim, Keriann M. Backus · 2021 · Organic & Biomolecular Chemistry
19. Integration of CRISPR/Cas9 with artificial intelligence for improved cancer therapeutics
    Ajaz Ahmad Bhat, Sabah Nisar, Soumi Mukherjee, Nirmalya Saha, Nageswari Yarravarapu, Saife Niaz Lone, Tariq Masoodi, Ravi Chauhan, Selma Maacha, Puneet Bagga et al. · 2022 · Journal of Translational Medicine
20. CRISPR-based gene editing technology and its application in microbial engineering
    Junwei Wei, Yingjun Li · 2023 · Engineering Microbiology
21. DCAF1-based PROTACs with activity against clinically validated targets overcoming intrinsic- and acquired-degrader resistance
    Martin Schröder, Martin Renatus, Xiaoyou Liang, Fabian Meili, Thomas Zoller, Sandrine Ferrand, François Gauter, Xiaoyan Li, Frederic D. Sigoillot, Scott Gleim et al. · 2024 · Nature Communications
22. CRISPR–Cas9-mediated gene knockout in primary human airway epithelial cells reveals a proinflammatory role for MUC18
    Hong Wei Chu, Cydney L. Rios, Chih-Jen Huang, Agata Wesolowska‐Andersen, Esteban G. Burchard, Brian P. O’Connor, Tasha E. Fingerlin, David P. Nichols, Susan D. Reynolds, Max A. Seibold · 2015 · Gene Therapy
23. LSD1-Mediated Epigenetic Reprogramming Drives CENPE Expression and Prostate Cancer Progression
    Yi Liang, Musaddeque Ahmed, Haiyang Guo, Fraser Soares, Junjie Tony Hua, Shuai Gao, Catherine Lu, Christine Poon, Wanting Han, Jens Langstein et al. · 2017 · Cancer Research
24. Exploiting an Asp-Glu “switch” in glycogen synthase kinase 3 to design paralog-selective inhibitors for use in acute myeloid leukemia
    Florence F. Wagner, Lina Benajiba, Arthur J. Campbell, Michel Weïwer, Joshua R. Sacher, Jennifer P. Gale, Linda S. Ross, Alexandre Puissant, Gabriela Alexe, Amy Saur Conway et al. · 2018 · Science Translational Medicine
25. KAT6A and ENL Form an Epigenetic Transcriptional Control Module to Drive Critical Leukemogenic Gene-Expression Programs
    Fangxue Yan, Jinyang Li, Jelena Milosevic, Ricardo Petroni, Suying Liu, Zhennan Shi, Salina Yuan, Janice M. Reynaga, Yuwei Qi, Joshua Rico et al. · 2021 · Cancer Discovery
26. Iron‐induced NCOA4 condensation regulates ferritin fate and iron homeostasis
    Sota Kuno, Hiroaki Fujita, Yuki Tanaka, Yasumitsu Ogra, Kazuhiro Iwaï · 2022 · EMBO Reports
27. Size distributions of intracellular condensates reflect competition between coalescence and nucleation
    Daniel S.W. Lee, Chang-Hyun Choi, David W. Sanders, Lien Beckers, Joshua A. Riback, Clifford P. Brangwynne, Ned S. Wingreen · 2023 · Nature Physics
28. Limiting endosomal damage sensing reduces inflammation triggered by lipid nanoparticle endosomal escape
    Serena Omo‐Lamai, Yufei Wang, Manthan N. Patel, Aleksa Milosavljevic, Daniel W. Zuschlag, Subhajit Poddar, Jichuan Wu, Liuqian Wang, Fengyi Dong, Carolann L. Espy et al. · 2025 · Nature Nanotechnology
29. Pooled genome-wide CRISPR screening for basal and context-specific fitness gene essentiality in Drosophila cells
    Viswanatha, Raghuvir, Li, Zhongchi, Hu, Yanhui, Perrimon, Norbert · 2018 · eLife
30. Advancing chimeric antigen receptor T cell therapy with CRISPR/Cas9
    Jiangtao Ren, Yangbing Zhao · 2017 · Protein & Cell
31. PinAPL-Py: A comprehensive web-application for the analysis of CRISPR/Cas9 screens
    Philipp N. Spahn, Tyler Bath, Ryan J. Weiss, Jihoon Kim, Jeffrey D. Esko, Nathan E. Lewis, Olivier Harismendy · 2017 · Scientific Reports
32. 3′ Uridylation Confers miRNAs with Non-canonical Target Repertoires
    Acong Yang, Xavier Bofill‐De Ros, Tiejuan Shao, Minjie Jiang, Katherine Li, Patricia Villanueva, Lisheng Dai, Shuo Gu · 2019 · Molecular Cell
33. Inadequate DNA Damage Repair Promotes Mammary Transdifferentiation, Leading to BRCA1 Breast Cancer
    Hua Wang, Dongxi Xiang, Ben Liu, Aina He, Helena J. Randle, Kelvin Xi Zhang, Anushka Dongre, Norman Sachs, Allison P. Clark, Luwei Tao et al. · 2019 · Cell
34. Challenges in delivery systems for CRISPR-based genome editing and opportunities of nanomedicine
    Victor Aaron Sioson, Minjong Kim, Jinmyoung Joo · 2021 · Biomedical Engineering Letters
35. Targeting DHX9 Triggers Tumor-Intrinsic Interferon Response and Replication Stress in Small Cell Lung Cancer
    Takahiko Murayama, Jun Nakayama, Xinpei Jiang, Kenichi Miyata, Alexander D. Morris, Kathy Qi Cai, Rahul M. Prasad, Xueying Ma, Andrey Efimov, Neel Belani et al. · 2024 · Cancer Discovery
36. Targeted delivery of CRISPR interference system against Fabp4 to white adipocytes ameliorates obesity, inflammation, hepatic steatosis, and insulin resistance
    Jee Young Chung, Qurrat Ul Ain, Yoonsung Song, Seok‐Beom Yong, Yong‐Hee Kim · 2019 · Genome Research
37. Model-based understanding of single-cell CRISPR screening
    Duan, Bin, Zhou, Chi, Zhu, Chengyu, Yu, Yifei, Li, Gaoyang, Zhang, Shihua, Zhang, Chao, Ye, Xiangyun, Ma, Hanhui, Qu, Shen et al. · 2019 · Nature Communications
38. MDA5 plays a critical role in interferon response during hepatitis C virus infection
    Xuezhi Cao, Qiang Ding, Jie Li Lu, Wanyin Tao, Bing S Huang, Yanan Zhao, Junqi Niu, Yongjun Liu, Jin Zhong · 2014 · Journal of Hepatology
39. Functional variomics and network perturbation: connecting genotype to phenotype in cancer
    S. Stephen Yi, Shengda Lin, Yongsheng Li, Wei Zhao, Gordon Brent Mills, Nidhi Sahni · 2017 · Nature Reviews Genetics
40. Host determinants of adeno-associated viral vector entry
    Sirika Pillay, Jan E. Carette · 2017 · Current Opinion in Virology
41. JMJD6 Licenses ERα-Dependent Enhancer and Coding Gene Activation by Modulating the Recruitment of the CARM1/MED12 Co-activator Complex
    Weiwei Gao, Rong-quan Xiao, Wenjuan Zhang, Yiren Hu, Bing‐ling Peng, Wenjuan Li, Yaohui He, Haifeng Shen, Jian‐cheng Ding, Qi-xuan Huang et al. · 2018 · Molecular Cell
42. Functional Genomics via CRISPR–Cas
    Kyle M. Ford, Daniella McDonald, Prashant Mali · 2018 · Journal of Molecular Biology
43. New genes drive the evolution of gene interaction networks in the human and mouse genomes
    Wenyu Zhang, Patrick Landback, Andrea R. Gschwend, Bairong Shen, Manyuan Long · 2015 · Genome biology
44. miR-514a regulates the tumour suppressor NF1 and modulates BRAFi sensitivity in melanoma
    Mitchell S. Stark, Vanessa Bonazzi, Glen M. Boyle, Jane M. Palmer, Judith Symmons, Catherine M. Lanagan, Christopher Schmidt, Adrian C. Herington, Robert Ballotti, Pamela M. Pollock et al. · 2015 · Oncotarget
45. Genome Editing Reveals Glioblastoma Addiction to MicroRNA-10b
    Rachid El Fatimy, Shruthi Subramanian, Erik J. Uhlmann, Anna M. Krichevsky · 2017 · Molecular Therapy
46. CHO-omics review: the impact of current and emerging technologies on Chinese hamster ovary based bioproduction
    Stolfa, Gino, Smonskey, Matthew T., Boniface, Ryan, Hachmann, Anna‐Barbara, Gulde, Paul, Joshi, Atul D., Pierce, Anson P., Jacobia, Scott J., Campbell, Andrew · 2018 · Biotechnology Journal
47. Gene drive systems: do they have a place in agricultural weed management?
    Paul Neve · 2018 · Pest Management Science
48. CRISPR-Cas13 System as a Promising and Versatile Tool for Cancer Diagnosis, Therapy, and Research
    Fahreddin Palaz, Ali Kerem Kalkan, Özgür Can, Ayça Nur Demir, Abdullah Tozluyurt, Ahsen Özcan, Mehmet Özsöz · 2021 · ACS Synthetic Biology
49. CRISPR/Cas System and Factors Affecting Its Precision and Efficiency
    Nasir Javaid, Sangdun Choi · 2021 · Frontiers in Cell and Developmental Biology
50. Genome-Scale CRISPR screen identifies LAPTM5 driving lenvatinib resistance in hepatocellular carcinoma
    Jiaomeng Pan, Mao Zhang, Liangqing Dong, Shuyi Ji, Juan Zhang, Shu Jie Zhang, Youpei Lin, Xiaoying Wang, Zhen‐Bin Ding, Shuang–Jian Qiu et al. · 2022 · Autophagy
51. Genetic screens and functional genomics using CRISPR /Cas9 technology
    Ella Hartenian, John G. Doench · 2015 · FEBS Journal
52. Targeting Non-proteolytic Protein Ubiquitination for the Treatment of Diffuse Large B Cell Lymphoma
    Yibin Yang, Priscilla N. Kelly, Arthur L. Shaffer, Roland Schmitz, Hee Min Yoo, Xinyue Liu, Da Wei Huang, Daniel E. Webster, Ryan M. Young, Masao Nakagawa et al. · 2016 · Cancer Cell
53. Genome Editing in Human Stem Cells
    Susan M. Byrne, Prashant Mali, George McDonald Church · 2014 · Methods in enzymology on CD-ROM/Methods in enzymology
54. Genome-wide CRISPR-KO Screen Uncovers mTORC1-Mediated Gsk3 Regulation in Naive Pluripotency Maintenance and Dissolution
    Meng Li, Jason Yu, Katarzyna Tilgner, Swee Hoe Ong, Hiroko Koike-Yusa, Kosuke Yusa · 2018 · Cell Reports
55. Stem cell bioengineering: building from stem cell biology
    Mukul Tewary, Nika Shakiba, Peter W. Zandstra · 2018 · Nature Reviews Genetics
56. Stromal cell senescence contributes to impaired endometrial decidualization and defective interaction with trophoblast cells
    Pavel I. Deryabin, Aleksandra V. Borodkina · 2022 · Human Reproduction
57. Spatial Transcriptomics: Technical Aspects of Recent Developments and Their Applications in Neuroscience and Cancer Research
    Han‐Eol Park, Song Hyun Jo, Rosalind H. Lee, Christian P. Macks, Taeyun Ku, Jihwan Park, Chung Whan Lee, Junho K. Hur, Chang Ho Sohn · 2023 · Advanced Science
58. Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-Thalassemia
    Dinah V. Parums · 2024 · Medical Science Monitor
59. Structural and kinetic analysis of the COP9-Signalosome activation and the cullin-RING ubiquitin ligase deneddylation cycle
    Mosadeghi, Ruzbeh, Reichermeier, Kurt M, Winkler, Martin, Schreiber, Anne, Reitsma, Justin M, Zhang, Yaru, Stengel, Florian, Cao, Junyue, Kim, Minsoo, Sweredoski, Michael J et al. · 2016 · eLife
60. Next-generation libraries for robust RNA interference-based genome-wide screens
    Martin Kampmann, Max A. Horlbeck, Yuwen Chen, Jordan C. Tsai, Michael Cory Bassik, Luke A. Gilbert, Jacqueline E. Villalta, S. Chul Kwon, Hyeshik Chang, V. Narry Kim et al. · 2015 · Proceedings of the National Academy of Sciences
61. Plant genome engineering in full bloom
    Jorge Lozano‐Juste, Sean R. Cutler · 2014 · Trends in Plant Science
62. Single-cell and multivariate approaches in genetic perturbation screens
    Prisca Liberali, Berend Snijder, Lucas Pelkmans · 2014 · Nature Reviews Genetics
63. In Vivo Delivery Systems for Therapeutic Genome Editing
    Luyao Wang, Fangfei Li, Lei Dang, Chao Liang, Chao Wang, Bing He, Jin Liu, Defang Li, Xiaohao Wu, Xuegong Xu et al. · 2016 · International Journal of Molecular Sciences
64. CRISPR-Cas9 therapeutics in cancer: promising strategies and present challenges
    Lang Yi, Jinming Li · 2016 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
65. Reprogramming cell fates by small molecules
    Xiaojie Ma, Linghao Kong, Saiyong Zhu · 2017 · Protein & Cell
66. Simultaneous Knockout of CXCR4 and CCR5 Genes in CD4+ T Cells via CRISPR/Cas9 Confers Resistance to Both X4- and R5-Tropic Human Immunodeficiency Virus Type 1 Infection
    Songlin Yu, Yongchao Yao, Hongkui Xiao, Jiaojiao Li, Quan Liu, Yijun Yang, Dickson Adah, Junnan Lu, Siting Zhao, Qin Li et al. · 2017 · Human Gene Therapy
67. A High-Resolution Genome-Wide CRISPR/Cas9 Viability Screen Reveals Structural Features and Contextual Diversity of the Human Cell-Essential Proteome
    Thierry Bertomeu, Jasmin Coulombe‐Huntington, Andrew Chatr‐aryamontri, Karine G. Bourdages, Étienne Coyaud, Brian Raught, Yu Xia, Mike Tyers · 2017 · Molecular and Cellular Biology
68. The IFN Response in Bats Displays Distinctive IFN-Stimulated Gene Expression Kinetics with Atypical RNASEL Induction
    Pamela C. De La Cruz-Rivera, Mohammed Kanchwala, Hanquan Liang, Ashwani Kumar, Lin‐Fa Wang, Chao Xing, John W. Schoggins · 2017 · The Journal of Immunology
69. Combinatorial CRISPR-Cas9 Metabolic Screens Reveal Critical Redox Control Points Dependent on the KEAP1-NRF2 Regulatory Axis
    Dongxin Zhao, Mehmet G. Badur, Jens Luebeck, Jose H. Magaña, Amanda Birmingham, Roman Šášik, Christopher S. Ahn, Trey Ideker, Christian M. Metallo, Prashant Mali · 2018 · Molecular Cell
70. Cancer-Associated MORC2-Mutant M276I Regulates an hnRNPM-Mediated CD44 Splicing Switch to Promote Invasion and Metastasis in Triple-Negative Breast Cancer
    Fang-Lin Zhang, Jin-Ling Cao, Hong-Yan Xie, Rui Sun, Li-Feng Yang, Zhi‐Ming Shao, Da‐Qiang Li · 2018 · Cancer Research
71. Multiple Routes to Oncogenesis Are Promoted by the Human Papillomavirus–Host Protein Network
    Manon Eckhardt, Wei Zhang, Andrew M. Gross, John Von Dollen, Jeffrey R. Johnson, Kathleen E. Franks-Skiba, Danielle L. Swaney, Tasha Lynn Johnson, Gwendolyn Μ. Jang, Priya S. Shah et al. · 2018 · Cancer Discovery
72. CRISPR/Cas9-based epigenome editing: An overview of dCas9-based tools with special emphasis on off-target activity
    Vanja Tadić, Goran Josipović, Vlatka Zoldoš, Aleksandar Vojta · 2019 · Methods
73. Plant Virus Vectors 3.0: Transitioning into Synthetic Genomics
    Will B. Cody, Herman B. Scholthof · 2019 · Annual Review of Phytopathology
74. Organoids of the female reproductive tract
    Cindrilla Chumduri, Margherita Yayoi Turco · 2021 · Journal of Molecular Medicine
75. Viral vectors and extracellular vesicles: innate delivery systems utilized in CRISPR/Cas-mediated cancer therapy
    Seyed Esmaeil Ahmadi, Maral Soleymani, Fahimeh Shahriyary, Mohammad Reza Amirzargar, Ofoghi Mahya, Davood Fattahi, Majid Safa · 2023 · Cancer Gene Therapy
76. Smad2 and Smad3 have differential sensitivity in relaying TGFβ signaling and inversely regulate early lineage specification
    Ling Liu, Xu Liu, Xudong Ren, Yue Tian, Zhen‐Yu Chen, Xiangjie Xu, Yanhua Du, Cizhong Jiang, Yujiang Fang, Zhongliang Liu et al. · 2016 · Scientific Reports
77. PRMT5-mediated regulation of developmental myelination
    Antonella Scaglione, Julia Patzig, Jialiang Liang, Rebecca Frawley, Jabez Bok, Angeliki Mela, Camila Yattah, Jingxian Zhang, Shun Xie Teo, Ting Zhou et al. · 2018 · Nature Communications
78. scMAGeCK links genotypes with multiple phenotypes in single-cell CRISPR screens
    Yang, Lin, Zhu, Yuqing, Yu, Hua, Cheng, Xiaolong, Chen, Sitong, Chu, Yulan, Huang, He, Zhang, Jin, Li, Wei · 2020 · Genome Biology
79. Hit and go CAS9 delivered through a lentiviral based self-limiting circuit
    Petris, Gianluca, Casini, Antonio, Montagna, Claudia, Lorenzin, Francesca, Prandi, Davide, Romanel, Alessandro, Zasso, Jacopo, Conti, Luciano, Demichelis, Francesca, Cereseto, Anna · 2017 · Nature Communications
80. Off‐target effects of engineered nucleases
    Jiing‐Kuan Yee · 2016 · FEBS Journal
81. Frameshift indels introduced by genome editing can lead to in-frame exon skipping
    Simon Lalonde, Oliver Andrew Stone, Samuel Lessard, Adam Lavertu, Jessica Desjardins, Mélissa Beaudoin, Manuel A. Rivas, Didier Y. R. Stainier, Guillaume Lettre · 2017 · PLoS ONE
82. PICKLES: the database of pooled in-vitro CRISPR knockout library essentiality screens
    W. Frank Lenoir, Tassica L Lim, Traver Hart · 2017 · Nucleic Acids Research
83. CRISPR/Cas9 mediated targeting of multiple genes in Dictyostelium
    Ryoya Sekine, Takefumi Kawata, Tetsuya Muramoto · 2018 · Scientific Reports
84. Drug resistance of BRAF-mutant melanoma: Review of up-to-date mechanisms of action and promising targeted agents
    Alessandro Rossi, Michela Roberto, Martina Panebianco, Andrea Botticelli, Federica Mazzuca, Paolo Marchetti · 2019 · European Journal of Pharmacology
85. Application of CRISPR/Cas9 to human-induced pluripotent stem cells: from gene editing to drug discovery
    Claudia De Masi, Paola Spitalieri, Michela Murdocca, Giuseppe Novelli, Federica Carla Sangiuolo · 2020 · Human Genomics
86. Interplay between Cellular Metabolism and the DNA Damage Response in Cancer
    Amandine Moretton, Joanna I. Loizou · 2020 · Cancers
87. Elongation factor ELOF1 drives transcription-coupled repair and prevents genome instability
    Marit E. Geijer, Di Zhou, Kathiresan Selvam, Barbara Steurer, Chirantani Mukherjee, Bastiaan Evers, Simona Cugusi, Marvin van Toorn, Melanie van der Woude, Roel C. Janssens et al. · 2021 · Nature Cell Biology
88. Genome-scale screens identify factors regulating tumor cell responses to natural killer cells
    Michal Sheffer, Emily Lowry, Nicky A. Beelen, Minasri Borah, Suha Naffar-Abu Amara, Chris C. Mader, Jennifer A. Roth, Aviad Tsherniak, Samuel S. Freeman, Olga Dashevsky et al. · 2021 · Nature Genetics
89. GEPIA3: Enhanced drug sensitivity and interaction network analysis for cancer research
    Yu-Jian Kang, Lingjie Pan, Yiyu Liu, Zhengqin Rong, Jiaxi Liu, Fenglin Liu · 2025 · Nucleic Acids Research
90. A Genome-Wide CRISPR Screen Identifies Genes Critical for Resistance to FLT3 Inhibitor AC220
    Panpan Hou, Chao Wu, Yuchen Wang, Rui Qi, Dheeraj Bhavanasi, Zhixiang Zuo, Cédric Dos Santos, Shuliang Chen, Yu Zheng Chen, Hong Zheng et al. · 2017 · Cancer Research
91. A validated gRNA library for CRISPR/Cas9 targeting of the human glycosyltransferase genome
    Yoshiki Narimatsu, Hiren Jitendra Joshi, Zhang Yang, Catarina Gomes, Yen‐Hsi Chen, Flaminia Clelia Lorenzetti, Sanae Furukawa, Katrine T.-B. G. Schjoldager, Lars Hestbjerg Hansen, Henrik Clausen et al. · 2017 · Glycobiology
92. SIRT6 haploinsufficiency induces BRAFV600E melanoma cell resistance to MAPK inhibitors via IGF signalling
    Thomas Strub, Flávia G. Ghiraldini, Saul Carcamo, Man Li, Aleksandra Wroblewska, Rajendra Singh, Matthew S. Goldberg, Dan Hasson, Zichen Wang, Stuart J. Gallagher et al. · 2018 · Nature Communications
93. Interrogating the protein interactomes of RAS isoforms identifies PIP5K1A as a KRAS-specific vulnerability
    Hema Adhikari, Christopher M. Counter · 2018 · Nature Communications
94. An inflammatory-CCRK circuitry drives mTORC1-dependent metabolic and immunosuppressive reprogramming in obesity-associated hepatocellular carcinoma
    Hanyong Sun, Weiqin Yang, Yuan Tian, Xuezhen Zeng, Jingying Zhou, Myth T.S. Mok, Wenshu Tang, Yu Feng, Liangliang Xu, Anthony W.H. Chan et al. · 2018 · Nature Communications
95. Delivering SaCas9 mRNA by lentivirus-like bionanoparticles for transient expression and efficient genome editing
    Baisong Lu, Parisa Javidi-Parsijani, Vishruti S. Makani, Farideh Mehraein‐Ghomi, Walaa Mohamed Sarhan, Dongjun Sun, Kyung Whan Yoo, Zachary Atala, Pin Lyu, Anthony Atala · 2019 · Nucleic Acids Research
96. The role of ZAP and OAS3/RNAseL pathways in the attenuation of an RNA virus with elevated frequencies of CpG and UpA dinucleotides
    Valerie Odon, Jelke Jan Fros, Niluka Goonawardane, Isabelle Dietrich, Ahmad Ibrahim, Kinda Alshaikhahmed, Dung V. Nguyen, Peter Simmonds K · 2019 · Nucleic Acids Research
97. A Highly Scalable Method for Joint Whole-Genome Sequencing and Gene-Expression Profiling of Single Cells
    Vasilios Zachariadis, Huaitao Cheng, Nathanael Andrews, Martin Enge · 2020 · Molecular Cell
98. O-GlcNAcylation of MORC2 at threonine 556 by OGT couples TGF-β signaling to breast cancer progression
    Yingying Liu, Hongyi Liu, Tian‐Jian Yu, Qin Lu, Fanglin Zhang, Guang‐Yu Liu, Zhi‐Ming Shao, Da‐Qiang Li · 2022 · Cell Death and Differentiation
99. TRIM9 short isoform preferentially promotes DNA and RNA virus-induced production of type I interferon by recruiting GSK3β to TBK1
    Yunfei Qin, Qingxiang Liu, Shuo Tian, Weihong Xie, Jun Cui, Rong‐Fu Wang · 2016 · Cell Research
100. SAMHD1 controls cell cycle status, apoptosis and HIV-1 infection in monocytic THP-1 cells
     Serena Bonifati, Michele B. Daly, Corine St. Gelais, Sun‐Hee Kim, Joseph A. Hollenbaugh, Caitlin Shepard, Edward M. Kennedy, Dong.-Hyun. Kim, Raymond F. Schinazi, Baek Kim et al. · 2016 · Virology